Today's Daily Dose brings you news about Invitae's secondary offering; BIOLASE's fourth-quarter financial results; Celgene's regulatory catalyst in September; and Endologix's reverse stock split, and the resignation of Scott Gottlieb as FDA Commissioner.
Original Article: BIOL On Watch, CELG Faces FDA In Sep., Scott Gottlieb Resigns